Studies on the Toxicological Effects of PFOA and PFOS on Rats Using Histological Observation and Chemical Analysis
The DOI matches its Crossref record; 44 of the 45 references it cites were found in a registry or an index.
Abstract
As an emerging class of environmentally persistent and bioaccumulative contaminants, perfluorinated compounds (PFCs), especially perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS), have been ubiquitously found in the environment. Increasing evidence shows that the accumulated levels of PFCs in animals and the human body might cause potential impairment to their health. In the present study, toxicological effects of PFOA and PFOS on male Sprague-Dawley rats were examined after 28 days of subchronic exposure. Abnormal behavior and sharp weight loss were observed in the high-dose PFOS group. Marked hepatomegaly, renal hypertrophy, and orchioncus in treated groups were in accordance with the viscera-somatic indexes of the liver, kidney, and gonad. Histopathological observation showed that relatively serious damage occurred in the liver and lung, mainly including hepatocytic hypertrophy and cytoplasmic vacuolation in the livers and congestion and thickened epithelial walls in the lungs. PFOA concentrations in main target organs were in the order of kidney > liver > lung > (heart, whole blood) > testicle > (spleen, brain), whereas the bioaccumulation order for PFOS was liver > heart > kidney > (whole blood) > lung > (testicle, spleen, brain). The highest concentration of PFOA detected in the kidney exposed to 5 mg/kg/day was 228+/-37 microg/g and PFOS in the liver exposed to 20 mg/kg/day reached the highest level of 648+/-17 microg/g, indicating that the liver, lung…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Global Distribution of Perfluorooctane Sulfonate in Wildlife
Giesy, J. P., & Kannan, K. (2001) · Environmental Science & Technology · doi:10.1021/es001834k · Cited by 2,750 · cited 2×
“They can be transferred, bioaccumulated, and biomagnified along food chains and their presence has been found in various tissues of many wildlife species and even in the human body ( Giesy and Kannan 2001; Houde et al. 2006; Kannan et al. 2004).”
BackgroundBiological Monitoring of Polyfluoroalkyl Substances: A Review
Houde, M., Martin, J. W., Letcher, R. J., Solomon, K. R., & Muir, D. C. G. (2006) · Environmental Science & Technology · doi:10.1021/es052580b · Cited by 1,262 · cited 1×
“They can be transferred, bioaccumulated, and biomagnified along food chains and their presence has been found in various tissues of many wildlife species and even in the human body (Giesy and Kannan 2001; Houde et al. 2006; Kannan et al. 2004).”
BackgroundPeer Reviewed: Perfluorochemical Surfactants in the Environment
Giesy, J. P., & Kannan, K. (2002) · Environmental Science & Technology · doi:10.1021/es022253t · Cited by 1,100
Perfluorooctanesulfonate and related fluorochemicals in human blood from several countries
Kannan, K., Corsolini, S., Falandysz, J., Fillmann, G., Kumar, K. S., Loganathan, B. G., Mohd, M. A., Olivero, J., Wouwe, N. V., Yang, J. H., et al. (2004) · Environmental Science & Technology · doi:10.1021/es0493446 · Cited by 1,056
Compound-specific, quantitative characterization of organic fluorochemicals in biological matrices
Hansen, K. J., Clemen, L. A., Ellefson, M. E., & Johnson, H. O. (2001) · Environmental Science & Technology · doi:10.1021/es001489z · Cited by 923 · cited 1×
“Sample pretreatments for the analysis of PFOA and PFOS in tissue samples were in accordance to previous references with some minor modifications ( Hansen et al. 2001 ).”
ResultThe Developmental Toxicity of Perfluoroalkyl Acids and Their Derivatives
Lau, C., Butenhoff, J. L., & Rogers, J. M. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2003.11.031 · Cited by 867 · cited 1×
“PFOA and PFOS were also considered as potent peroxisome proliferators in rats, mice, and rhesus ( Abdellatif and Preat 1990, 1999; Dzhekova et al. 2001; Panaretakis et al. 2001), and the peroxisome proliferation induced by both chemicals especially at a high dose caused the formation of hepatocellular hypertrophy (Hau…”
BackgroundThe toxicology of perfluorooctanoate
Kennedy, G. L., Butenhoff, J. L., Olsen, G. W., O'Connor, J. C., Seacat, A. M., Perkins, R. G., Biegel, L. B., Murphy, S. R., & Farrar, D. G. (2004) · Critical Reviews in Toxicology · doi:10.1080/10408440490464705 · Cited by 742
Fluorinated organics in the biosphere
Key, B. D., Howell, R. D., & Criddle, C. S. (1997) · Environmental Science & Technology · doi:10.1021/es961007c · Cited by 729 · cited 1×
“Perfluorinated compounds (PFCs) have been widely used in industrial application and civilian production because of their high stability and strong lipophobic and hydrophobic properties (Giesy and Kannan 2002; Key et al. 1997 ).”
BackgroundExposure to Perfluorooctane Sulfonate during Pregnancy in Rat and Mouse. II: Postnatal Evaluation
Lau, C., Thibodeaux, J. R., Hanson, R. G., Rogers, J. M., Grey, B. E., Stanton, M. E., Butenhoff, J. L., & Stevenson, L. A. (2003) · Toxicological Sciences · doi:10.1093/toxsci/kfg122 · Cited by 549 · cited 1×
“Easy absorption (orally [ 95%) and poor elimination of PFOS ( Lau et al. 2004 ) might well explain its bioaccumulation profiles.”
BackgroundThibodeaux, J. R., Hanson, R. G., Rogers, J. M., Grey, B. E., Barbee, B. D., Richards, J. H., Butenhoff, J. L., Stevenson, L. A., & Lau, C. (2003) · Toxicological Sciences · doi:10.1093/toxsci/kfg121 · Cited by 445
Binding of Perfluorooctanoic Acid to Rat and Human Plasma Proteins
Han, X., Snow, T. A., Kemper, R. A., & Jepson, G. W. (2003) · Chemical Research in Toxicology · doi:10.1021/tx034005w · Cited by 408 · cited 1×
“Once the binding sites of PFOA in serum or tissues came to saturation, the excretion of PFOA would increase in urine and feces ( Han et al. 2003 ).”
BackgroundSub-chronic dietary toxicity of potassium perfluorooctanesulfonate in rats
Seacat, A. M., Thomford, P. J., Hansen, K. J., Clemen, L. A., Eldridge, S. R., Elcombe, C. R., & Butenhoff, J. L. (2003) · Toxicology · doi:10.1016/s0300-483x(02)00511-5 · Cited by 400 · cited 3×
“attributed to proliferation of peroxisome, smooth endoplasmic reticulum, and mitochondria (Berthiaume and Wallace 2002; Pastoor et al. 1987 ), but not hepatocellular hyperplasia (no increase in nuclear DNA).”
BackgroundInfluentialInteractions of flurochemicals with rat liver fatty acid-binding protein
Luebker, D. J., Hansen, K. J., Bass, N. M., Butenhoff, J. L., & Seacat, A. M. (2002) · Toxicology · doi:10.1016/s0300-483x(02)00081-1 · Cited by 391 · cited 1×
“The liver, as the predominant accumulation tissue for PFOS (648 lg/g in G4), showed corresponding histological changes as shown in Fig. 5c, d. There is evidence that some specific proteins in the liver can bind with PFOS, which might contribute to the preferential accumulation of PFOS therein ( Luebker et al. 2002 ).”
BackgroundNeuroendocrine Effects of Perfluorooctane Sulfonate in Rats
Austin, M. E., Kasturi, B. S., Barber, M., Kannan, K., MohanKumar, P. S., & MohanKumar, S. M. J. (2003) · Environmental Health Perspectives · doi:10.1289/ehp.6128 · Cited by 347 · cited 2×
“The occurrence of PFOS in the brain indicated that it could cross the blood–brain barrier and result in potential adverse effects on rats, which was confirmed by the finding of the increase of serum corticosterone levels and the decrease of serum leptin concentrations due to PFOS exposure (Austin et al. 2003).”
BackgroundThe Pulmonary Surfactant System: Biochemical and Clinical Aspects
Creuwels, L. A. J. M., van Golde, L. M. G., & Haagsman, H. P. (1997) · Lung · doi:10.1007/pl00007554 · Cited by 304
Sex hormone-regulated renal transport of perfluorooctanoic acid
Kudo, N., Katakura, M., Sato, Y., & Kawashima, Y. (2002) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00006-6 · Cited by 291 · cited 1×
“It has been testified that renal transport of PFOA into urine is by a transporter, whose expression is regulated by sex hormones ( Kudo et al. 2002 ).”
BackgroundHarada, K., Inoue, K., Morikawa, A., Yoshinaga, T., Saito, N., & Koizumi, A. (2005) · Environmental Research · doi:10.1016/j.envres.2004.12.003 · Cited by 284 · cited 1×
“However, for PFOS, a lower renal clearance was observed, which was confirmed by the relatively longer half-life ([ 90 days) in the organisms when compared to PFOA ( Harada et al. 2005; Thibodeaux et al. 2003).”
BackgroundBiomagnification of Perfluoroalkyl Compounds in the Bottlenose Dolphin (Tursiops truncatus) Food Web
Houde, M., Bujas, T. A. D., Small, J., Wells, R. S., Fair, P. A., Bossart, G. D., Solomon, K. R., & Muir, D. C. G. (2006) · Environmental Science & Technology · doi:10.1021/es060233b · Cited by 279
Ohmori, K., Kudo, N., Katayama, K., & Kawashima, Y. (2003) · Toxicology · doi:10.1016/s0300-483x(02)00573-5 · Cited by 249 · cited 1×
“The available toxicokinetics studies indicated the slower elimination of PFOS compared to PFOA (Johnson et al. 1979; Ohmori et al. 2003 ), which was confirmed by accumulation profiles of both compounds observed herein (Table 1). Previous research also showed that LD50 values of PFOA and PFOS for male rats were 430‐680…”
BackgroundBerthiaume, J., & Wallace, K. B. (2002) · Toxicology Letters · doi:10.1016/s0378-4274(01)00466-0 · Cited by 246 · cited 2×
“PFCs were found to increase the numbers and size of peroxisomes, induce peroxisomal fatty acid b-oxidation, accelerate CYP450-mediated x-hydroxylation of lauric acid, and bring about the hypolipemic effect ( Berthiaume and Wallace 2002; Haughom and Spydevold 1992; Ikeda et al. 1985).”
BackgroundGene Expression Profiles in Rat Liver Treated With Perfluorooctanoic Acid (PFOA)
Guruge, K. S., Yeung, L. W. Y., Yamanaka, N., Miyazaki, S., Lam, P. K. S., Giesy, J. P., Jones, P. D., & Yamashita, N. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfj011 · Cited by 234
Andersen, M. E., Clewell, H. J., Tan, Y.-M., Butenhoff, J. L., & Olsen, G. W. (2006) · Toxicology · doi:10.1016/j.tox.2006.08.004 · Cited by 205 · cited 1×
“The requirement of urinary clearance for PFOA elevated transporter protein levels in urinary filtrate, which accelerated the resorption of PFOA in the kidney (Andersen et al. 2006).”
BackgroundHaughom, B., & Spydevold, Ø. (1992) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(92)90258-w · Cited by 172 · cited 2×
“PFCs were found to increase the numbers and size of peroxisomes, induce peroxisomal fatty acid b-oxidation, accelerate CYP450-mediated x-hydroxylation of lauric acid, and bring about the hypolipemic effect (Berthiaume and Wallace 2002; Haughom and Spydevold 1992; Ikeda et al. 1985).”
BackgroundPanaretakis, T., Shabalina, I. G., Grandér, D., Shoshan, M. C., & DePierre, J. W. (2001) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2001.9159 · Cited by 168
Surfactant phospholipids: synthesis and storage
Batenburg, J. J. (1992) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1992.262.4.l367 · Cited by 166 · cited 1×
“neonatal death in humans due to respiratory distress syndrome (Batenburg 1992; Creuwels et al. 1997; Hallman et al. 2001), was the major cause of death and severe pulmonary injury in rats.”
BackgroundIKEDA, T., AIBA, K., FUKUDA, K., & TANAKA, M. (1985) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a135302 · Cited by 164
Pharmacokinetics of Perfluorooctanoate in Cynomolgus Monkeys
Butenhoff, J. L. (2004) · Toxicological Sciences · doi:10.1093/toxsci/kfh302 · Cited by 151 · cited 1×
“It could be explained that urinary excretion is the primary route for depuration of PFOA in laboratory animals (Butenhoff et al. 2004; Kemper 2003), leading to the preferential deposition of PFOA in the kidney.”
BackgroundEffects of peroxisome proliferators on the thymus and spleen of mice
Yang, Q., Xie, Y., & Depierre, J. W. (2008) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2000.01367.x · Cited by 143
The handbook of environmental chemistry
(1987) · Environmental Pollution · doi:10.1016/0269-7491(87)90063-7 · Cited by 131
Identification of genes responsive to PFOS using gene expression profiling
Hu, W., Jones, P. D., Celius, T., & Giesy, J. P. (2004) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2004.04.008 · Cited by 119 · cited 1×
“Genes significantly induced by PFOS treatment were primarily those for fatty-acid-metabolizing enzymes, CYP450, or those involved in hormone regulation ( Hu et al. 2005 ).”
BackgroundGrasty, R. C., Grey, B. E., Lau, C. S., & Rogers, J. M. (2003) · Birth Defects Research Part B: Developmental and Reproductive Toxicology · doi:10.1002/bdrb.10046 · Cited by 118 · cited 2×
“The lung is another important target organ in addition to the liver in rats (Dean et al. 1978; Grasty et al. 2003 ).”
BackgroundResultInfluentialSurfactant in respiratory distress syndrome and lung injury
Hallman, M., Glumoff, V., & Rämet, M. (2001) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/s1095-6433(01)00324-5 · Cited by 108 · cited 1×
“neonatal death in humans due to respiratory distress syndrome (Batenburg 1992; Creuwels et al. 1997; Hallman et al. 2001 ), was the major cause of death and severe pulmonary injury in rats.”
BackgroundPastoor, T. P., Lee, K. P., Perri, M. A., & Gillies, P. J. (1987) · Experimental and Molecular Pathology · doi:10.1016/0014-4800(87)90011-6 · Cited by 93
The modulation of rat liver carcinogenesis by perfluorooctanoic acid, a peroxisome proliferator
ABDELLATIF, A. (1991) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(91)90257-f · Cited by 77 · cited 1×
“PFOA and PFOS were also considered as potent peroxisome proliferators in rats, mice, and rhesus ( Abdellatif and Preat 1990, 1999; Dzhekova et al. 2001; Panaretakis et al. 2001), and the peroxisome proliferation induced by both chemicals especially at a high dose caused the formation of hepatocellular hypertrophy (Hau…”
BackgroundDisposition of perfluorooctanoic acid in the rat after single and subchronic administration
Ylinen, M., Kojo, A., Hanhijärvi, H., & Peura, P. (1990) · Bulletin of Environmental Contamination and Toxicology · doi:10.1007/bf01702360 · Cited by 68 · cited 1×
“Contrary, slight splenic atrophy was observed in mice by Yang et al. (2000) and in rats by Goldenthal et al. (1978).”
BackgroundLysosomal-type PLA2and turnover of alveolar DPPC
Fisher, A. B., & Dodia, C. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.280.4.l748 · Cited by 53
Subcellular Distribution and Protein Binding of Perfluorooctanoic Acid in Rat Liver and Kidney
Han, X., Kemper, R., & Jepson, G. (2005) · Drug and Chemical Toxicology · doi:10.1081/dct-200052547 · Cited by 48 · cited 1×
“It has been suggested that PFOA could bind with some specific proteins, such as albumin (an important binding protein) in serum or tissues ( Han et al. 2005 ).”
BackgroundAbdellatif, A. G., Véronique Préat, A., Vamecq, J., Nilsson, R., & Roberfroid, M. B. (1990) · Carcinogenesis · doi:10.1093/carcin/11.11.1899 · Cited by 46
Peroxisome Proliferators: Their Biological and Toxicological Effects
Dzhekova-Stojkova, S., Bogdanska, J., & Stojkova, Z. (2001) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2001.076 · Cited by 44 · cited 1×
“PFOA and PFOS were also considered as potent peroxisome proliferators in rats, mice, and rhesus (Abdellatif and Preat 1990, 1999; Dzhekova et al. 2001; Panaretakis et al. 2001), and the peroxisome proliferation induced by both chemicals especially at a high dose caused the formation of hepatocellular hypertrophy (Haug…”
BackgroundO’Brien, M. L., Cunningham, M. L., Spear, B. T., & Glauert, H. P. (2001) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2000.9111 · Cited by 41
Hosokawa, M., & Satoh, T. (1993) · Xenobiotica · doi:10.3109/00498259309059427 · Cited by 38 · cited 1×
“The increase of the total cytochrome P-450 (CYP450) content, benzphetamine N-demethylase activity (Pastoor et al. 1987), and carboxylesterase activity ( Hosokawa and Satoh 1993 ) were found along with the hyperplasia of the smooth endoplasmic reticulum in the exposed rat liver (Pastoor et al. 1987).”
BackgroundPeroxisome proliferator perfluorodecanoic acid alters glutathione and related enzymes
Chen, L., Tatum, V. L., Glauert, H. P., & Chow, C. K. (2001) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.6 · Cited by 14 · cited 1×
“Although the toxicity mechanism of PFCs is still not clear, it is commonly accepted that PFCs could result in the induction of hepatic catalase, acyl-CoA oxidase, and glutathione by altering cytosolic enzymes activities, such as glutathionerelated enzymes in rodent liver ( Chen et al. 2001; DePierre 2002; O’Brien et a…”
BackgroundEffects on Rodents of Perfluorofatty Acids
DePierre, J. W. (2006) · Springer eBooks · doi:10.1007/10721878_7 · Cited by 4
Zhang, P., Yali, S., Ya-qi, C., & Shi-Fen, M. (2007) · Research Center for Eco-Environmental Sciences OpenIR (Chinese Academy of Sciences) · Cited by 4
Research works printed but not linked: 5
- Butenhoff JL, York R, Seacat A, Luebker D (2002) Perfluorooctanesulfonate-induced perinatal mortality in rat pups is associated with a steep dose-response. Toxicologist 66:25
- DuPont Haskell Laboratory (1982) Excretion and disposition of 14C-ammonium perfluorooctanoate in male and female rats, mice, hamsters, and rabbits. US EPA Public Docket AR-226. US Environmental Protection agency, Washington, DC
- Fisher AB, Dodia C (2001) Lysosomal-type PLA2 and turnover of alveolar DPPC. Am J Physiol 280:L748–L754
- Kouji H, Kayoko I, Akiko M, Takeo Y, Norimitsu S, Akio K (2005) Renal clearance of perfluorooctane sulfonate and perfluorooctanoate in humans and their species-specific excretion. Environ Res 99:253–261. doi: 10.1016/j.envres.2004.12.003 · DOI · Paper page
- US EPA (2005) Draft risk assessment of the potential human health effects associated with exposure to perfluorooctanoic acid. US Environmental Protection Agency, Washington, DC
Cited by
Fenton, S. E., Ducatman, A., Boobis, A., DeWitt, J. C., Lau, C., Ng, C., Smith, J. S., & Roberts, S. M. (2020) · Environmental Toxicology and Chemistry · doi:10.1002/etc.4890 · Cited by 2,445
(CONTAM), E. P. O. C. I. T. F. C., Knutsen, H. K., Alexander, J., Barregård, L., Bignami, M., Brüschweiler, B., Ceccatelli, S., Cottrill, B., Dinovi, M., Edler, L., et al. (2018) · EFSA Journal · doi:10.2903/j.efsa.2018.5194 · Cited by 515
“This is supported by studies finding that the bioaccumulation of PFOA is generally lower than for PFOS (Conder et al., 2008; Cui et al., 2009).”
BackgroundToxicology of perfluorinated compounds
Stahl, T., Mattern, D., & Brunn, H. (2011) · Environmental Sciences Europe · doi:10.1186/2190-4715-23-38 · Cited by 432
Dickman, R. A., & Aga, D. S. (2022) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2022.129120 · Cited by 365
“1) (DeWitt et al., 2009; Gordon, 2011; Cui et al., 2008; Trudel et al., 2008) because they are the most used forms and are stable end products of other PFAS precursors.”
Sen, P., Qadri, S., Luukkonen, P. K., Ragnarsdottir, O., McGlinchey, A., Jäntti, S., Juuti, A., Arola, J., Schlezinger, J. J., Webster, T. F., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2021.09.039 · Cited by 290
Metadata
- Authors
- Cui, L., Zhou, Q.-F., Liao, C.-Y., Fu, J.-J., & Jiang, G.-B.
- Affiliations
- Chinese Academy of Sciences (CN)
- ORCID
- Cui, Lin
- Venue
- Archives of Environmental Contamination and Toxicology
- Published
- 2008-07-26
- Volume
- 56
- Issue
- 2
- Pages
- 338-349
- ISSN
- 0090-4341 (ISSN-L)
- 1432-0703
- OpenAlex
- W2087691088
- Cited by
- 368
- References
- 45
- Citations by year
- 2026: 23 · 2025: 39 · 2024: 34 · 2023: 35 · 2022: 29 · 2021: 28 · 2020: 18 · 2019: 20 · 2018: 19 · 2017: 12 · 2016: 14 · 2015: 20 · 2014: 23 · 2013: 13 · 2012: 9
- FWCI
- 7.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Archives of Environmental Contamination and Toxicology (publishedVersion)
- PubMed (publishedVersion)
- Research Center for Eco-Environmental Sciences OpenIR (Chinese Academy of Sciences) (submittedVersion)
- Funders
- National Natural Science Foundation of China
- Chinese Academy of Sciences
- Ministry of Science and Technology of the People's Republic of China
- Topics
- Physical Sciences › Environmental Science › Environmental Chemistry › Per- and polyfluoroalkyl substances research
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Toxic Organic Pollutants Impact
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Environmental Toxicology and Ecotoxicology
- Keywords
- perfluorooctanoic acid, PFOS, perfluorinated compounds, subchronic exposure, hepatomegaly, renal hypertrophy, liver histopathology, lung histopathology, tissue distribution, bioaccumulation, dose-dependent accumulation, target organs
- MeSH terms
- Animals, Behavior, Animal, Body Weight, Caprylates, Dose-Response Relationship, Drug, Environmental Pollutants, Fluorocarbons, Kidney, Liver, Lung, Male, Organ Specificity, Tissue Distribution, Rats, Sprague-Dawley, Alkanesulfonic Acids, Toxicity Tests, Chronic, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.